Author:
Rupérez María,Pou Christian,Maculuve Sonia,Cedeño Samandhy,Luis Leopoldina,Rodríguez Judith,Letang Emilio,Moltó José,Macete Eusébio,Clotet Bonaventura,Alonso Pedro,Menéndez Clara,Naniche Denise,Paredes Roger
Funder
Gilead Sciences
Rio Hortega from the Spanish Ministry of Health
European Developing Countries Clinical Trials Partnership
Malaria in Pregnancy Consortium and the Instituto de Salud Carlos III
Spanish Agency for International Cooperation (AECI)
Agencia Catalana de Cooperació al Desenvolupament (ACCD)
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)
Reference48 articles.
1. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings
2. WHO. Antiretroviral Medicines in Low- and Middle-income Countries: Forecasts of Global and Regional Demand for 2012–2015. http://www.who.int/hiv/pub/amds/2013forecast_report/en/ .
3. WHO. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection. Recommendations for a Public Health Approach. http://apps.who.int/iris/bitstream/10665/85321/1/9789241505727_eng.pdf .
4. Public-Health and Individual Approaches to Antiretroviral Therapy: Township South Africa and Switzerland Compared
5. Immunologic Criteria Are Poor Predictors of Virologic Outcome: Implications for HIV Treatment Monitoring in Resource-Limited Settings